Position in LFCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,697
New position
Shares Held
725
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HARBOUR INVESTMENTS, INC. holds $1,215,976 across 37 Drug Manufacturers - Specialty & Generic names. LFCR ranks #25 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,164 | $255,806 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
10,014 | $207,890 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
8,107 | $150,141 | |
| 4 | VTRS |
Viatris Inc
|
10,434 | $140,963 | |
| 5 | HROW |
Harrow, Inc.
|
1,970 | $69,462 | |
| 6 | HLN |
Haleon plc
|
5,879 | $58,848 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,553 | $46,776 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
73 | $43,287 |
All Filings in LFCR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,697 | 725 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||